219 related articles for article (PubMed ID: 11355165)
1. New developments in the pathology of skull base tumors.
Radner H; Katenkamp D; Reifenberger G; Deckert M; Pietsch T; Wiestler OD
Virchows Arch; 2001 Apr; 438(4):321-35. PubMed ID: 11355165
[TBL] [Abstract][Full Text] [Related]
2. Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.
Sangoi AR; Dulai MS; Beck AH; Brat DJ; Vogel H
Am J Surg Pathol; 2009 May; 33(5):669-81. PubMed ID: 19194275
[TBL] [Abstract][Full Text] [Related]
3. Pathological classification and molecular genetics of meningiomas.
Mawrin C; Perry A
J Neurooncol; 2010 Sep; 99(3):379-91. PubMed ID: 20809251
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathogenesis of meningiomas.
Perry A; Gutmann DH; Reifenberger G
J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477
[TBL] [Abstract][Full Text] [Related]
5. Aggressive rhabdoid meningioma with osseous, papillary and chordoma-like appearance.
Karabagli P; Karabagli H; Yavas G
Neuropathology; 2014 Oct; 34(5):475-83. PubMed ID: 24702318
[TBL] [Abstract][Full Text] [Related]
6. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic meningioma: progression from atypical and chordoid morphotype with morphologic spectral variation at recurrence.
Bollag RJ; Vender JR; Sharma S
Neuropathology; 2010 Jun; 30(3):279-87. PubMed ID: 19780983
[TBL] [Abstract][Full Text] [Related]
8. [Meningiomas: new prognostic factors].
Sanz Esponera J
An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
[TBL] [Abstract][Full Text] [Related]
9. Current treatment options for meningioma.
Apra C; Peyre M; Kalamarides M
Expert Rev Neurother; 2018 Mar; 18(3):241-249. PubMed ID: 29338455
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
11. Correlation of DNA content and nucleomorphometric features with World Health Organization grading of meningiomas.
Grunewald JP; Röhl FW; Kirches E; Dietzmann K
Mod Pathol; 1998 Feb; 11(2):216-23. PubMed ID: 9504694
[TBL] [Abstract][Full Text] [Related]
12. Pathology of skull base tumors.
Richardson MS
Otolaryngol Clin North Am; 2001 Dec; 34(6):1025-42, vii. PubMed ID: 11728930
[TBL] [Abstract][Full Text] [Related]
13. [Variants in the growth of meningiomas of the base of the skull spreading into the orbit and paranasal sinuses].
Cherekaev VA; Makhmudov UB; Osolodchenko LV; Taniashin SV; Vinokurov AG
Zh Vopr Neirokhir Im N N Burdenko; 1998; (3):25-31. PubMed ID: 9854783
[TBL] [Abstract][Full Text] [Related]
14. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas.
McGovern SL; Aldape KD; Munsell MF; Mahajan A; DeMonte F; Woo SY
J Neurosurg; 2010 May; 112(5):925-33. PubMed ID: 19799498
[TBL] [Abstract][Full Text] [Related]
15. A radiopathological classification of dural tail sign of meningiomas.
Qi ST; Liu Y; Pan J; Chotai S; Fang LX
J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
[TBL] [Abstract][Full Text] [Related]
16. Clear cell meningiomas: three case reports with genetic characterization and review of the literature.
Ohba S; Sasaki H; Kimura T; Ikeda E; Kawase T
Neurosurgery; 2010 Sep; 67(3):E870-1; discussion E871. PubMed ID: 20683214
[TBL] [Abstract][Full Text] [Related]
17. [The new WHO classification of tumors of the nervous system 2000. Pathology and genetics].
Radner H; Blümcke I; Reifenberger G; Wiestler OD
Pathologe; 2002 Jul; 23(4):260-83. PubMed ID: 12185780
[TBL] [Abstract][Full Text] [Related]
18. Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases.
Cornelius JF; Slotty PJ; Steiger HJ; Hänggi D; Polivka M; George B
Acta Neurochir (Wien); 2013 Mar; 155(3):407-13. PubMed ID: 23318687
[TBL] [Abstract][Full Text] [Related]
19. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas.
Combs SE; Schulz-Ertner D; Debus J; von Deimling A; Hartmann C
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1415-21. PubMed ID: 20932661
[TBL] [Abstract][Full Text] [Related]
20. Classification of meningiomas-advances and controversies.
Harter PN; Braun Y; Plate KH
Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S2. PubMed ID: 28595423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]